Product
AP-SA02
1 clinical trial
5 indications
Indication
BacteremiaIndication
Staphylococcus aureusIndication
Staphylococcus aureus bacteremiaIndication
Bacteremia, StaphIndication
Bacteremia Due to Staphylococcus AureusClinical trial
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy for the Treatment of Adults With Bacteremia Due to Staphylococcus AureusStatus: Recruiting, Estimated PCD: 2024-12-01